NasdaqGS:ALKSBiotechs
Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative?
Alkermes plc recently reported past second-quarter 2026 results, with revenue rising to US$496.01 million while net income fell sharply to US$0.50 million, and the company issued guidance calling for third-quarter 2026 revenue of US$450 million to US$470 million alongside an expected full-year 2026 GAAP net loss of US$95 million to US$115 million.
At the same time, Alkermes paused buybacks after repurchasing 5.32% of its shares since 2024 and filed a US$311.11 million employee share plan...